PT-141
PT-141, also called Bremelanotide (generic clinical name), is a heavily modified synthetic derivative of alpha-melanocyte-stimulating hormone. It has been tested in clinical trials as a treatment for both male/female hypoactive sexual desire disorder and acute hemorrhage. PT-141 is an agonist for the melanocortin-4 and melanocortin-1 receptors. Research shows that it promotes sexual arousal and stimulates the immune system.
PT-141 (3mg x 10 Vials = 30mg)
PT-141, also called Bremelanotide (generic clinical name), is a heavily modified synthetic derivative of alpha-melanocyte-stimulating hormone. It has been tested in clinical trials as a treatment for both male/female hypoactive sexual desire disorder and acute hemorrhage. PT-141 is an agonist for the melanocortin-4 and melanocortin-1 receptors. Research shows that it promotes sexual arousal and stimulates the immune system.
PT-141 (Bremelanotide) 10mg
PT-141, also known as Bremelanotide, is a synthetic peptide analog derived from the melanocortin peptide family. It is primarily studied in neuroscience and endocrine research due to its interaction with melanocortin receptors, which are involved in complex signaling pathways affecting central nervous system communication and cellular regulation.
